Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Lupus. 2015 Jan 16;24(9):900–908. doi: 10.1177/0961203314566635

Table 4.

Multivariate Linear Regression Analysis of Risk Factors for WOMAC Pain and Function Outcomes after THA*

Parameter Estimate Standard Error 95% Confidence Intervals P-value
WOMAC pain at 2 years
SLE vs. OA 3.95 3.28 −2.47 10.4 0.23
WOMAC Pain at Baseline 0.14 0.09 −0.04 0.32 0.12
PCS at Baseline 0.46 0.22 0.03 0.90 0.04
MCS at Baseline 0.24 0.11 0.02 0.46 0.03
WOMAC Function at 2 years
SLE vs. OA 2.66 3.85 −4.90 10.2 0.49
WOMAC Function at Baseline 0.32 0.11 0.10 0.54 0.01
PCS at Baseline 0.15 0.31 −0.45 0.75 0.62
MCS at Baseline 0.35 0.13 0.10 0.60 0.01
*

Multivariate linear regression controlling for diagnosis, baseline WOMAC pain and function, and baseline MCS and PCS.

Bolding indicates a statistically significant value.